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A B S T R A C T
A simple, accurate and sensitive high-performance liquid chromatography (HPLC) method was developed,
validated and applied to the determination of either theophylline or paracetamol in milk-based samples. The
method allowed drug quantification in fresh and powdered milk with a relatively short run time of analysis and
it was also successfully applied to the quantification of the drugs in solid dosage forms intended for pediatric
use. Moreover, the main significant advantages over other published works are the simplicity of the sample
preparation, reduced assay time and sample loss. The method meets the International Conference on
Harmonization guideline for analytical methods validation regarding specificity, linearity, accuracy, precision,
specificity and robustness as required by health authorities and applied by industry while designing and
marketing new drug products. The technique encompasses the separation of the analytes with a reverse phase
C18 column under isocratic conditions and UV detection at 272 nm and 243 nm, respectively, for theophylline
and paracetamol. The lower limit of quantification for both drugs was determined as 0.2 µg/mL and the
between-batch accuracy was 99.7%. This HPLC method allows quantification of theophylline and paracetamol
in milk matrices and it can be applied in the design, development and production of milk-based pediatric dosage
forms.
1. Introduction
Theophylline and paracetamol are drugs extensively used both in
human and veterinary medicine. Theophylline is a potent bronchodi-
lator used in the treatment of bronchial asthma, infant apnea and
chronic obstructive pulmonary disease [1]. On the other hand, para-
cetamol (or acetaminophen) acceptance and effectiveness is proven as
analgesic and antipyretic in adults and children; in fact, it is the drug of
choice in pediatric palliative care and is considered essential for child
survival [2].
Pediatric use of both drugs requires constant dose adjustment
based on children's characteristics, namely body weight or surface area.
Breast-fed infants are also likely to be exposed to residues of theophyl-
line and paracetamol taken by nursing mothers, who can pass the drugs
into the breast milk; another possible drug sources are foods of animal
origin [3], such as commercial powdered or fresh milk. Due to the
possible liver toxicity (paracetamol) and narrow therapeutic index
(theophylline), it is imperative to carefully select and monitor the
amount of drug (intentional or involuntary) administered to children in
order to avoid toxicity and undesirable side effects.
Children's unique therapeutic needs have recently led to new
pediatric regulations [4,5] and development of medicines specifically
designed for this age group [6,7]. In this respect, milk has been
proposed as a platform to deliver drugs in pediatrics [8,9] due to its
lack of toxicity and acceptability by children. Milk components have
also been used as vehicles for active drug ingredients [10,11] and
nutraceuticals [12]. Since milk is a universally accepted food and plays
a key role in the development of neonates and infants [13], incorpora-
tion of drugs in this matrix is likely to improve compliance to drug
therapy.
This new perspective in pediatric drug delivery has prompted the
development of a simple and sensitive analytical methodology for
quantification of both theophylline and paracetamol in the complex
matrix that milk represents. There are several published methods for
determination of theophylline or paracetamol individually, or in
combination with other drugs, in different matrices, but there is a lack
of similar studies involving quantification of paracetamol or theophyl-
line in powdered or fresh milk and none, to our knowledge, involves
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quantification of these drugs in milk-based dosage forms. Just to name
a few works, theophylline was quantified by high-performance liquid
chromatography (HPLC) in urine, saliva and plasma samples [14]
alone and, in combination with etophylline, in human plasma [15],
breast milk [16,17] and tablets [18]; paracetamol was quantified by
UV–Vis and HPLC in tablets [19–22] and biological fluids [23].
Reports of HPLC drug determinations as residues in breast milk were
found for several drugs [24], including paracetamol and theophylline
[17], but those methods require extensive pretreatment of samples to
remove matrix interference.
The aim of this work was to develop a HPLC method accepted by
health authorities (i.e. complying with ICH guidelines), and easily
performed by users (e.g. pharmaceutical industries), to quantify
theophylline and paracetamol, both in solid or liquid milk-based
dosage forms, intended for pediatric use.
2. Materials and methods
2.1. Raw materials and reagents
Fresh (Mimosa, Lactogal Produtos Alimentares S.A., Porto,
Portugal) and powdered (Nido®, Nestlé Portugal, Oeiras, Portugal)
commercial milk were purchased from a high street market.
Paracetamol was supplied by Lusifar (Lisbon, Portugal) and theophyl-
line by Sigma-Aldrich (Munich, Germany). Sodium croscarmellose (Ac-
Di-Sol®, FMC BioPolymer, Philadelphia, USA), D-mannitol (Carlo Erba,
Cornaredo, Italy) and magnesium stearate (Sigma-Aldrich, Munich,
Germany) were used. Ammonium acetate (Merck, Darmstadt,
Germany) and p-aminobenzoic acid (PABA) were of analytical grade
(≥ 99% purity), and methanol and acetonitrile were of HPLC grade
(Sigma-Aldrich, Munich, Germany). Ultrapure water (18.2 MΩ·cm),
obtained with a Milli-Q system (Merck Millipore, Bedford, USA), was
used throughout the study.
2.2. Equipment and chromatographic conditions
Chromatographic separation of paracetamol and theophylline was
performed at room temperature (23 °C) in a Merck®-Hitachi Lachrome
liquid chromatography system (Darmstadt, Germany) equipped with a
L-7400 UV–VIS detector, a quaternary pump, a manual injector
Rheodyne 7750i and a data system (D-7000 HSM software). A
Merck® analytical Purospher C18 column (250 mm × 4 mm internal
diameter; particle size 5 µm) and a Purospher C18 pre-column (4 mm ×
4 mm internal diameter; particle size 5 µm) were used. PABA was
included in every sample as an internal standard (IS). Chromatography
was carried out under isocratic conditions with a mobile phase
consisting of a mixture of ammonium acetate buffer-acetonitrile-
methanol (pH 6.0; 10 mM; 90:5:5, v/v/v), pumped at a 1 mL/min
flow rate. Analytes were quantified at 272 nm (theophylline) and
243 nm (paracetamol) and the run time of the assay was 13 min. A
20 µL injection volume was used for each analytical run; true triplicate
samples were considered and each was injected in triplicate.
2.3. Preparation of stock solutions, calibration standards and quality
control samples
Stock solutions of theophylline or paracetamol (1000 µg/mL) and
PABA (100 µg/mL) were prepared in ultrapure water. The calibration
solutions were prepared by diluting the drug stock solution with
appropriate quantities of sample matrix (water:milk; 90:10,v/v), to
obtain standard solutions with concentrations of 0.2, 0.5, 1, 2.5, 10, 20,
25, 50 and 75 μg/mL. In preliminary tests, different calibration curves
were constructed using milk containing different fat contents
(high−HFM; medium−MFM; low−LFM), as described before. Since
the milk fat content did not interfere with the assay (data not shown)
fat milk was used thereof to prepare the calibration solutions of the
developing method. PABA final concentration in calibration solutions
was 5 μg/mL. The quality control samples were prepared by dissolving
the appropriate amount of drug in a 90:10 mixture of water: milk
(90:10, v/v), at concentrations of the lower limit of quantification
(LLOQ=0.2 μg/mL), low (0.5 µg/mL), medium (5 µg/mL), high
(25 µg/mL) and upper limit of quantification (ULOQ=75 μg/mL) for
both theophylline and paracetamol.
2.4. Preparation of milk-based dosage forms containing theophylline
or paracetamol
To reproduce the milk matrices in which theophylline and/or
paracetamol were to be quantified, solid dosage forms (powders and
minitablets containing known amounts of the model drugs; Table 1)
intended for pediatric use were initially produced respectively from
fresh and powdered commercial milk. In short, theophylline was
dispersed in fresh milk with different fat contents (low, medium and
high) to attain different concentrations and the resulting mixtures were
spray-dried to obtain powders. Spray-drying was performed in a Mini
Spray-Dryer B-191 (Büchi Labortechik GmbH, Flawil, Switzerland),
using a feed liquid rate of 4 mL/min (i.e. 20%) and an atomizing air
rate of 600 L/h, at a 3 bar atomizing pressure and a constant aspiration
airflow rate of 100%, as previously described [8]. Minitablets (2.5 mm
diameter) were obtained from mixtures of powdered milk (whole fat)
and paracetamol in different proportions (mannitol, sodium croscar-
mellose and magnesium stearate were used as excipients) and pro-
duced by direct compression in a mechanical press (LR 50 K, Lloyds
Instruments, Leicester, UK) at 178 GPa, as described elsewhere [9].
Five different batches of both spray-dried powders and minitablets
were prepared and stored, at room temperature (23 ± 1 °C) and 65%
relative humidity, until further use.
2.5. Sample preparation
Pharmaceutical samples, i.e. powders containing theophylline and
minitablets containing paracetamol, were used as model milk matrices
for drug quantification. Just prior to analysis the dosage forms were
suspended/dissolved by vortexing in ultrapure water (10 mL). After
dilution, drug concentration in samples was expected to range from 0
to 47.6 μg/mL for powders and from 0 to 50.9 μg/mL for minitablets.
Fresh milk and drug-milk solutions (0.1 mL) were used respectively as
negative and positive controls, and diluted with ultrapure water to a
final concentration within the linear range of the method. PABA final
concentration in calibration solutions was 5 μg/mL. The mixtures,
prepared in triplicate, were then centrifuged (2000 rpm for 10 min)
and 20 µL of the supernatant was injected and analyzed in triplicate.
2.6. Analytical method validation
The proposed HPLC method was validated according to the
Table 1
Quantification of theophylline in spray-dried milk powders and paracetamol in milk-
based minitablets.
Drug Amount expected (mg/g) Amount found (mg/g) CV (%)
Theophylline 0 0.00 0.0
200 200.98 3.1
450 451.12 1.9
780 780.82 1.5
Paracetamol 0 0.00 0.0
160 159.91 2.6
400 400.85 1.8
640 640.76 1.6
Since fat content was found irrelevant, data obtained in fat milk matrices is presented as
an example. Results are the mean of true replicate samples (n=3), injected in triplicate.
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International Conference on Harmonization of Technical
Requirements for Registration of Pharmaceuticals for Human Use
(ICH) Q2(R1) guideline [25], with respect to specificity, linearity,
accuracy, precision, limit of detection (LOD) and LOQ and robustness.
Linearity was assessed by plotting the peak area ratios of the drug/
IS against the corresponding drug concentration (ranging from 0.2 μg/
mL to 75 μg/mL). Calibration curves were based on nine standards
quantified in triplicate and generated by least-squares linear regression
analysis.
Accuracy and precision were evaluated by repeated analysis of
theophylline and paracetamol in milk. Intra-day and inter-day preci-
sion was assessed by variation studies, in repeated analysis (n=6) of
control samples at five concentrations levels, LLOQ (0.2 µg/mL), low
(0.5 µg/mL), medium (5 µg/mL), high (25 µg/mL) and ULOQ (75 µg/
mL), for both drugs, on the same day and on separate days. The
accuracy (recovery test) was determined as the percentage of deviation
between nominal and measured concentrations of the analytes (n=6) at
the same five concentrations. The mean peak areas of the milk control
samples spiked with known amounts of each drug were compared with
the accepted true values (the known drug concentrations), taken as
corresponding to 100% recovery. The overall precision was expressed
as coefficient of variation (CV, %) and the accuracy of the method as
recovery rate (RR, %).
Specificity was ascertained from analysis of chromatograms ob-
tained with milk (control) and milk samples containing both drugs.
Analytical interference from milk components was investigated in
whole fat reconstituted powdered milk and in fresh milk with three
fat concentrations (LFM, MFM and HFM).
The LOD was measured as the signal-to-noise ratio of 3:1 and the
LLOQ was determined as three times the LOD. The LLOQ was validated
by repeated analysis of samples (n=5) prepared at the quantitation limit
and the maximum acceptable deviation was set at 10%.
Robustness was evaluated by changing key method parameters
such as temperature (25 °C and 30 °C) and pH (5.5, 6.0, 6.5) and
monitoring for substantial changes in retention, resolution, and peak
shape.
3. Results and discussion
The establishment of an efficient method for quantitation of
paracetamol and theophylline in milk-based dosage forms was para-
mount for the development of these novel way of delivering drugs to
children [8,9]. Conventional analytical techniques described in the
literature such as UV–Vis spectrophotometry [19–21] proved to be
inappropriate because of the difficulty to attain reliable and reprodu-
cible results, due to interference of the milk matrix, and more sensitive
HPLC methods described in the literature were tried instead [26,27].
However, these methods required a complicated and time-consuming
precipitation of milk proteins prior to injection, with a significant loss
(20%–41%) of the analytes. To obviate these problems, the method
herein described was adapted from the work of Nirogi et al. [15]. Initial
chromatographic conditions were chosen considering the availability of
columns and the chemical properties of the drugs. A pre-column was
included to minimize interference from milk components and extend
the life of the column, since sample preparation did not involve the
usual protein precipitation. The mobile phase solvent strength and pH
were adjusted to obtain a satisfactory quantification with minimal time
of analysis.
In fact, the main significant advantage of the present method is the
simplicity of the sample preparation since measurements are made
directly on the liquid (or solid upon dilution or suspension in water)
samples. Another advantage is the relatively short run time (13 min) of
the analysis, under isocratic conditions; retention times for paraceta-
mol and theophylline were respectively 8.4 and 10.8 min (Fig. 1). To
note that the reported run time is the sum of the run time in the
column and in the pre-column, the retention time would be about
4 min shorter (as ascertained in previous experiments performed
without pre-column, data not shown) if the pre-column was not used.
It is challenging to compare the HPLC retention times of theophyl-
line and paracetamol with other published works since different
methods and/or matrices were used. As discussed in the
Introduction, in the literature we either find HPLC methods for
quantification of paracetamol or theophylline in simple matrixes, or
in human milk, as residues. Some works do not state retention times at
all [16,19–23] and others report shorter (between 5 and 6.6 min)
retention times for theophylline [14,15,18]. Paracetamol and theophyl-
line residues, quantified in breast milk, presented retention times of 9
and 18 min [17], respectively, which are comparable to our work
(paracetamol), or much higher (theophylline). Again, direct compar-
ison of results is precluded since Maithili et al. [17] did not use a pre-
column, but rather precipitated milk proteins to avoid interference of
the matrix.
To prove that the method was adequate for the intended use (assay
of drugs in dosage forms developed for pediatric use), as required by
regulatory agencies at certain stages of the drug approval process, it
was validated according to ICH Q2 (R1) guideline [25].
3.1. Linearity
Linearity of the method was established from calibration curves of
the standard solutions. Both calibration curves (9 points) for theophyl-
line and paracetamol were constructed ranging from 0.2 μg/mL to
75 μg/mL. The peak area ratios of the drug/IS were plotted against the
corresponding drug concentration. The mean linear regression equa-
tion of calibration curve for theophylline was y=0.5927x+0.0041 and
y=1.0568x+0.4618 for paracetamol, where y is the peak area ratio of
the analyte to the IS and x is the concentration of the analyte.
Calibration curves, generated using least-squares linear regression
analysis, were linear over the tested range, with squared correlation
coefficients (r2) of 0.999. The concentration of drugs in the pharma-
ceutical samples and controls were calculated (Table 1) from the
resulting equations.
Fig. 1. Typical chromatograms of (A) milk samples spiked with IS, (B) IS plus
paracetamol, and (C) IS plus theophylline. Concentration of both drugs was 50 μg/mL
and that of PABA was 5 μg/mL.
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3.2. Accuracy and precision
The average percentage recovery, calculated by comparing the
mean peak area of five control solutions (LLOQ, low, medium and
high, ULOQ) with their nominal concentrations, varied from 97.3% to
105.1% (mean between-batch variation 99.7%) with the CV ranging
from 2.6% to 8.2% (Table 2). These results indicate a high recovery
efficiency, repeatability and intermediate precision.
3.3. Suitability
The suitability of the method was evaluated for the quantitation of
the model drugs in five different batches of solid dosage forms
produced in-house. For theophylline samples, different fat contents
in the matrix were tested. Since the amount of fat in the milk matrix did
not significantly affect the recovery results, only data obtained with
samples produced with high fat milk are presented in Table 1. Drug
concentrations determined in the dosage forms considered were also in
agreement with the nominal values, with CV within 3.1%, thus
confirming the high recovery of the method.
3.4. Sensitivity
The LOD, defined as the concentration giving a 3:1 signal-to-noise,
was 0.067 μg/mL and the LLOQ, considered in this work as the lowest
concentration standard admitting acceptable accuracy and precision,
was 0.2 μg/mL for both drugs. Depending on the method and matrix
considered, the limit of quantification (LOQ) reported for theophylline
ranges from 0.1 μg/mL [15] to 6.0 μg/mL [18] and for paracetamol
from 0.26 μg/mL [19] to 20 μg/mL [20]. These results, as discussed
before, are, however, not directly comparable with ours. The LOD and
LOQ for paracetamol and theophylline residues present in breast milk
(the most similar matrix to that of the present work), have not been
reported [17].
3.5. Specificity
Specificity was investigated to determine if milk components (or
other excipients in the case of minitablets) interfered with the analytes
or the IS. Specificity was confirmed from the chromatograms (Fig. 1) of
blank fresh milk and milk spiked with either of the analytes. The
method was capable of accurately measuring the concentration of both
drugs without interference from milk components, regardless of the
presence of milk proteins and the milk fat content. No interfering peaks
or additional matrix effects were observed, probably due to the great
sample dilution and centrifugation, combined with the use of a pre-
column in the HPLC system.
3.6. Robustness
Deliberate small changes (pH, temperature) in HPLC analytical
parameters did not lead to significant changes in retention time values,
percentage of recovery and area, or symmetry of the peaks of both
drugs. The method is thus robust and expected to be reliable during
normal usage.
4. Conclusions
In this work, a sensitive, selective, accurate, precise and inexpensive
HPLC method for determination of paracetamol and theophylline in
fresh and powdered milk was validated. In fact, it was possible to
accurately measure the drugs, without interference from components
of the complex milk matrix, with minor sample handling. Moreover,
the method was successfully applied to the quantification of the drugs,
in the milk-based solid dosage forms considered.
The method can thus be applied to the pharmaceutical develop-
ment, production and quality control of milk-containing dosage forms
for pediatric use. Furthermore, the quantification of residues of the
same drugs in the milk of breast-feeding mothers and livestock, with
potential application both in the pharmaceutical and food industries,
should also be possible, provided the necessary adjustments are made.
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